Scientific Sessions 2024  /  Cardiometabolic Factors: Global Burden and Innovative Solutions  /  A New Era of Innovative Antihypertensive Treatment
Logo

American Heart Association

  100
  0

Final ID:

A New Era of Innovative Antihypertensive Treatment

  • Wang, Jiguang  ( , Shanghai , China )
    • Author Disclosures:
    Jiguang Wang: DO have relevant financial relationships ; Speaker:Novartis:Active (exists now) ; Speaker:Viatris:Active (exists now) ; Speaker:Servier:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Cardiometabolic Factors: Global Burden and Innovative Solutions

Sunday, 11/17/2024 , 09:45AM - 11:00AM

Global Roundtable

More abstracts on this topic:
Priorities for Improving Cardiometabolic Health in the Americas

Piskorz Daniel

Cardiorenal syndrome - The cardiologist perspective

Skalsky Keren

More abstracts from these authors:
Assessing the Impact of Aprocitentan on Systolic and Diastolic BP in Patients with Isolated Systolic Hypertension (ISH)-like Characteristics

Flack John, Narkiewicz Krzysztof, Schlaich Markus, Wang Jiguang, Weber Michael

The effect of aprocitentan in patients with very high blood pressure at baseline

Weber Michael, Narkiewicz Krzysztof, Schlaich Markus, Wang Jiguang, Flack John

You have to be authorized to contact abstract author. Please, Login
Not Available